First Time Loading...

Human Metabolome Technologies Inc
TSE:6090

Watchlist Manager
Human Metabolome Technologies Inc Logo
Human Metabolome Technologies Inc
TSE:6090
Watchlist
Price: 662 JPY 1.53% Market Closed
Updated: May 15, 2024

Human Metabolome Technologies Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Human Metabolome Technologies Inc
Cost of Revenue Peer Comparison

Comparables:
2309
2370
4880
2183
7079

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Human Metabolome Technologies Inc
TSE:6090
Cost of Revenue
-¥462.1m
CAGR 3-Years
-18%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Cost of Revenue
-¥72.3B
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
Medinet Co Ltd
TSE:2370
Cost of Revenue
-¥596.2m
CAGR 3-Years
-9%
CAGR 5-Years
2%
CAGR 10-Years
6%
CellSource Co Ltd
TSE:4880
Cost of Revenue
-¥1.3B
CAGR 3-Years
-30%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Cost of Revenue
-¥8.4B
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-14%
WDB coco Co Ltd
TSE:7079
Cost of Revenue
-¥2.5B
CAGR 3-Years
-21%
CAGR 5-Years
-20%
CAGR 10-Years
N/A

See Also

What is Human Metabolome Technologies Inc's Cost of Revenue?
Cost of Revenue
-462.1m JPY

Based on the financial report for Dec 31, 2023, Human Metabolome Technologies Inc's Cost of Revenue amounts to -462.1m JPY.

What is Human Metabolome Technologies Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-16%

Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Human Metabolome Technologies Inc have been -18% over the past three years , -16% over the past five years .